← FDA Drug Approvals (Drugs@FDA)
RIOCIGUAT
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2022-03-30
Drug application
- FDA Application #
ANDA211044- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIOCIGUAT
- Generic name
- Riociguat
- Active ingredients
- RIOCIGUAT
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- TEVA PHARMS USA INC
- First approval
- 2022-03-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown